Security key
74065P101
Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD)
CUSIP: 74065P101
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 65,427,364
- Total 13F shares
- 34,197,005
- Share change
- -513,088
- Total reported value
- $162,095,049
- Put/Call ratio
- 0%
- Price per share
- $4.74
- Number of holders
- 56
- Value change
- -$2,346,403
- Number of buys
- 22
- Number of sells
- 26
Report period
Q1 2024
Institutions
56
Top holders
10
PRLD full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Prelude Therapeutics Inc SEC filings
Prelude Therapeutics Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74065P101
Recent filing periods:
Top shareholders of PRLD - Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
17%
|
10,909,256
|
$46,582,523 | — | 31 Dec 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
15%
|
10,123,824
|
$43,228,728 | — | 31 Dec 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
6.3%
|
4,133,000
|
$17,647,910 | — | 31 Dec 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
3.9%
|
2,568,287
|
$10,966,585 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.7%
|
1,095,589
|
$4,678,165 | — | 31 Dec 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
1,042,737
|
$4,453,000 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
1,006,856
|
$4,299,275 | — | 31 Dec 2023 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.78%
|
510,749
|
$2,180,898 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.53%
|
349,367
|
$1,491,967 | — | 31 Dec 2023 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.49%
|
320,394
|
$1,368,082 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
298,796
|
$1,275,860 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
0.4%
|
264,687
|
$1,130,214 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.33%
|
216,400
|
$924,000 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.32%
|
212,234
|
$906,239 | — | 31 Dec 2023 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.25%
|
160,652
|
$685,984 | — | 31 Dec 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
148,749
|
$635,158 | — | 31 Dec 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.2%
|
131,307
|
$560,681 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.19%
|
124,700
|
$532,469 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
114,097
|
$487,194 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.15%
|
96,966
|
$414,045 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.15%
|
95,330
|
$407,060 | — | 31 Dec 2023 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.11%
|
70,165
|
$299,605 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
69,465
|
$296,616 | — | 31 Dec 2023 | |
| Pale Fire Capital SE |
13F
|
Company |
0.1%
|
63,581
|
$271,491 | — | 31 Dec 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
61,800
|
$263,886 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
58,284
|
$248,873 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
50,600
|
$216,062 | — | 31 Dec 2023 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.07%
|
44,087
|
$188,251 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
37,490
|
$160,083 | — | 31 Dec 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
32,977
|
$140,812 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
30,526
|
$130,346 | — | 31 Dec 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
29,418
|
$125,615 | — | 31 Dec 2023 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
24,800
|
$105,896 | — | 31 Dec 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.04%
|
23,210
|
$93,768 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
20,403
|
$87,113 | — | 31 Dec 2023 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
20,122
|
$85,921 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
19,873
|
$84,858 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
16,797
|
$71,723 | — | 31 Dec 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
15,495
|
$65,000 | — | 31 Dec 2023 | |
| Amundi |
13F
|
Individual |
0.02%
|
15,130
|
$61,428 | — | 31 Dec 2023 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
14,346
|
$61,257 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
14,305
|
$60,918 | — | 31 Dec 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
13,607
|
$58,000 | — | 31 Dec 2023 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
13,100
|
$56,000 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
9,380
|
$40,053 | — | 31 Dec 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
9,026
|
$39,000 | — | 31 Dec 2023 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
7,397
|
$31,585 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
4,599
|
$19,638 | — | 31 Dec 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,992
|
$17,046 | — | 31 Dec 2023 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
2,449
|
$10,457 | — | 31 Dec 2023 |
Institutional Holders of Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) as of Q1 2024
As of 31 Mar 2024,
Prelude Therapeutics Inc - Common Stock, $0.0001 par value per share (PRLD) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,197,005 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Boxer Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, GEODE CAPITAL MANAGEMENT, LLC, and Sio Capital Management, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
55
Q1 2024 holders
56
Holder diff
1
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.